Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC
ClinicalTrials.gov study NCT06300424. IPD Sharing: NO. Countries: 1. Publications: 0.
Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer
ClinicalTrials.gov study NCT02284633. IPD Sharing: NO. Countries: 1. Publications: 0.
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study
ClinicalTrials.gov study NCT04401059. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
To Evaluate the Efficacy of Afatinib in Advanced Lung Squamous Cell Carcinoma With EGFR Sensitive Mutation
ClinicalTrials.gov study NCT04132102. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III
ClinicalTrials.gov study NCT00620269. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium.
ClinicalTrials.gov study NCT01260038. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC
ClinicalTrials.gov study NCT05994131. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21
ClinicalTrials.gov study NCT01714908. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21)
ClinicalTrials.gov study NCT06295432. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor
ClinicalTrials.gov study NCT02496663. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positvie ctDNA After lead-in Osimertinib Monotherapy
ClinicalTrials.gov study NCT07375316. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.
ClinicalTrials.gov study NCT07274761. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical Mutations
ClinicalTrials.gov study NCT06674343. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Prevalence of EGFR Mutations in epidermoïd Bronchopulmonary Cancers in Réunion Island
ClinicalTrials.gov study NCT04261725. IPD Sharing: NO. Countries: 1. Publications: 0.
Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment
ClinicalTrials.gov study NCT06106802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An EGFR Co-amplified Long Noncoding RNA HELDR Promotes Glioblastoma Malignancy through KAT7-driven gene programs [ChIRP]
GEO Series GSE286432. Homo sapiens. 21 samples. Type: Genome binding/occupancy profiling by high throughput sequencing; Other.
miRNAs classifiers are powerful diagnostic/prognostic tools in ALK, EGFR, KRAS driven lung cancer
GEO Series GSE72526. Homo sapiens. 85 samples. Type: Non-coding RNA profiling by array.
Analysis of differentially expressed circRNAs after EGFR-TKI treatment
GEO Series GSE211854. Homo sapiens. 21 samples. Type: Expression profiling by high throughput sequencing; Non-coding RNA profiling by high throughput sequencing.
Tinagl1 Suppresses Triple-negative Breast Cancer Progression by Simultaneously Targeting Integrin/FAK and EGFR Signaling Pathways
GEO Series GSE99507. Homo sapiens. 6 samples. Type: Expression profiling by array.
An EGFR Co-amplified Long Noncoding RNA HELDR Promotes Glioblastoma Malignancy through KAT7-driven gene programs [Long-reads, GBM6]
GEO Series GSE286320. Homo sapiens. 1 samples. Type: Other.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.